SCHEMBL10150667

SCHEMBL10150667

C=CC(=O)OCCCCOC(=O)C12CC3CC(CC(C)(C3)C1)C2

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.48
ALDH1A1 P00352 6/20 0.45
TSHR P16473 5/20 0.45
CYP3A4 P08684 1/20 0.45
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.36
TP53 P04637 2/20 0.35
HIF1A Q16665 2/20 0.35
HSD17B10 Q99714 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
EPHX2 P34913 1/20 0.34
RXFP1 Q9HBX9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10150672 0.95 NPSR1 (0.50) NPSR1ALDH1A1TSHRCYP3A4HPGD
SCHEMBL10150634 0.82 NPSR1 (0.48) NPSR1ALDH1A1TSHRHTTMEN1
SCHEMBL19218032 0.77 NPSR1 (0.54) NPSR1ALDH1A1TSHRHTTMEN1
SCHEMBL10150658 0.77 TSHR (0.39) ALDH1A1TSHRCYP3A4HPGDTP53
SCHEMBL10150638 0.76 NPSR1 (0.50) NPSR1ALDH1A1TSHRHTTMEN1
SCHEMBL7799315 0.75 NPSR1 (0.55) NPSR1ALDH1A1TSHRHTTMEN1
SCHEMBL10150654 0.74 TSHR (0.38) NPSR1ALDH1A1TSHRCYP3A4HPGD
SCHEMBL10150668 0.74 ALDH1A1 (0.40) ALDH1A1TSHRCYP3A4HPGDMEN1
SCHEMBL13084353 0.74 NPSR1 (0.60) NPSR1ALDH1A1TSHREPHX2
SCHEMBL691868 0.74 NPSR1 (0.60) NPSR1ALDH1A1TSHREPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173350-B2 Oxime compound and resist composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-05-08 US disclosed
US-8173350-B2 Oxime compound and resist composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-05-08 US disclosed
US-20100021847-A1 Oxime Compound and Resist Composition Containing the Same SUMITOMO CHEMICAL COMPANY, LTD. (JP) 2010-01-28 US disclosed
US-20100021847-A1 Oxime Compound and Resist Composition Containing the Same SUMITOMO CHEMICAL COMPANY, LTD. (JP) 2010-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100021847-A1 Oxime Compound and Resist Composition Containing the Same CYC1, UQCRB, CBR1 NPSR1 2324/4885ALDH1A1 1280/4885TSHR 841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.